Synthesis and Characterization of pH-Responsive Sodium Alginate/Zein/γ- Alumina Nanocarriers for Targeted Curcumin Delivery in Lung Cancer DOI Creative Commons

Mohammad Najafi,

Davood Rabiei Faradonbeh,

Sakineh Hajebi

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 8, 2024

Abstract Stimulus-responsive drug delivery systems based on anticancer of curcumin constitute a promising strategy to overcome some challenges Lung cancer treatment. In the present study, pH-responsive nanocarriers were designed by sodium alginate (SA), zein, and γ-alumina (γ-Al2O3) as nanocarrier via W/O/W double emulsion technique facilitate targeted lung cells. The characterize physical interactions crystalline structure confirmed FTIR XRD, respectively. size drug-loaded nanocomposites was 218.6 nm with monodisperse particle distribution, having rod-like shape approved DLS analysis FE-SEM, Sensitivity samples pH studied using ultraviolet − visible spectroscopy. UV vis spectroscopy results display higher absorption intensities in acidic tumor conditions (pH 5.4) than physiological (7.4). method significantly enhanced loading entrapment efficiency compared other reported systems. Cytotoxicity cell death further analyzed MTT flow cytometry assays. These suggest that SA/zein/γ-Al2O3 nanocomposite is promise system for therapy.

Language: Английский

Rational design of polymeric micelles for targeted therapeutic delivery DOI
Yuting Zheng, Yavuz Oz, Y. D. Gu

et al.

Nano Today, Journal Year: 2024, Volume and Issue: 55, P. 102147 - 102147

Published: Jan. 18, 2024

Language: Английский

Citations

35

Peptide-Functionalized Polymeric Nanoparticles for Delivery of Curcumin to Cancer Cells DOI
Neda Rostami,

Aiada Ghebleh,

Hadi Noei

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 106337 - 106337

Published: Oct. 1, 2024

Language: Английский

Citations

11

Breaking barriers: Smart vaccine platforms for cancer immunomodulation DOI Creative Commons
Mohammad Mahmoudi Gomari,

Taha Ghantabpour,

Nima Pourgholamamiji

et al.

Cancer Communications, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 3, 2025

Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need explore alternative approaches such as vaccines. Leveraging immune system's natural ability target and kill cells holds great therapeutic potential. However, development of vaccines is hindered by several challenges, including low stability, inadequate response activation, immunosuppressive tumor microenvironment, which limit their efficacy. Recent progress various fields, click chemistry, nanotechnology, exosome engineering, neoantigen design, offer innovative solutions these challenges. These achievements have led emergence smart vaccine platforms (SVPs), integrate protective carriers for messenger ribonucleic acid (mRNA) with functionalization strategies optimize targeted delivery. Click chemistry further enhances SVP performance improving encapsulation mRNA antigens facilitating precise delivery review highlights latest developments technologies therapy, exploring both opportunities challenges advancing transformative approaches.

Language: Английский

Citations

1

Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing DOI Creative Commons
Neda Rostami, Mohammad Mahmoudi Gomari,

Edris Choupani

et al.

Small Science, Journal Year: 2024, Volume and Issue: unknown

Published: July 25, 2024

The genetic material within cells plays a pivotal role in shaping the structure and function of living organisms. Manipulating an organism's genome to correct inherited abnormalities or introduce new traits holds great promise. Genetic engineering techniques offers promising pathways for precisely altering cellular genetics. Among these methodologies, clustered regularly interspaced short palindromic repeat (CRISPR), honored with 2020 Nobel Prize Chemistry, has garnered significant attention its precision editing genomes. However, CRISPR system faces challenges when applied vivo, including low delivery efficiency, off-target effects, instability. To address challenges, innovative technologies targeted precise have emerged. Engineered carrier platforms represent substantial advancement, improving stability, precision, reducing side effects associated editing. These facilitate efficient local systemic various tissues cells, immune cells. This review explores recent advances, benefits, CRISPR-based delivery. It examines carriers nanocarriers (polymeric, lipid-derived, metallic, bionanoparticles), viral particles, virus-like exosomes, providing insights into their clinical utility future prospects.

Language: Английский

Citations

5

Advances in stimuli-responsive gold nanorods for drug-delivery and targeted therapy systems DOI Open Access
Sakineh Hajebi, Mohsen Chamanara,

Shadi Sadat Nasiri

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 180, P. 117493 - 117493

Published: Sept. 30, 2024

Language: Английский

Citations

5

Design, Synthesis, and Comparison of PLA-PEG-PLA and PEG-PLA-PEG Copolymers for Curcumin Delivery to Cancer Cells DOI Open Access
Neda Rostami, Farzaneh Faridghiasi,

Aida Ghebleh

et al.

Polymers, Journal Year: 2023, Volume and Issue: 15(14), P. 3133 - 3133

Published: July 23, 2023

Curcumin (CUR) has potent anticancer activities, and its bioformulations, including biodegradable polymers, are increasingly able to improve CUR’s solubility, stability, delivery cancer cells. In this study, copolymers comprising poly (L-lactide)-poly (ethylene glycol)-poly (L-lactide) (PLA-PEG-PLA) glycol) (PEG-PLA-PEG) were designed synthesized assess compare their CUR-delivery capacity inhibitory potency on MCF-7 breast Molecular dynamics simulations free energy analysis indicated that PLA-PEG-PLA a higher propensity interact with the cell membrane more negative energy, suggesting it is better carrier for penetration. To characterize copolymer synthesis, Fourier transform-infrared (FT-IR) proton nuclear magnetic resonance (1H-NMR) employed, size was measured using dynamic light scattering (DLS), surface charge determined by zeta potential analysis. Characterization ring-opening polymerization (ROP) reaction optimal synthesizing high-quality polymers. Microspheres then successfully. Of two formulations, experimentally exhibited results, an initial burst release of 17.5%, followed slow, constant encapsulated drug up 80%. PLA-PEG-PLA-CUR showed significant increase in death cells (IC50 = 23.01 ± 0.85 µM) based MTT assay. These data consistent gene expression studies Bax, Bcl2, hTERT, which induced apoptosis efficiently these Through integration nano-informatics vitro approaches, our study system delivering curcumin inhibit

Language: Английский

Citations

13

Microfluidic-Assisted Silk Nanoparticles Co-Loaded with Epirubicin and Copper Sulphide: A Synergistic Photothermal–Photodynamic Chemotherapy Against Breast Cancer DOI Creative Commons
Zijian Gao,

Muhamad Hawari Mansor,

Faith Howard

et al.

Nanomaterials, Journal Year: 2025, Volume and Issue: 15(3), P. 221 - 221

Published: Jan. 30, 2025

Phototherapy, including photodynamic therapy (PDT) and photothermal (PTT), has emerged as a promising non-invasive cancer treatment, addressing issues like drug resistance systemic toxicity common in conventional breast therapies. Recent research shown that copper sulphide (CuS) nanoparticles polydopamine (PDA) exhibit exceptional conversion efficiency under 808 nm near-infrared (NIR) laser irradiation, making them valuable for phototherapy. However, the effectiveness of PDT is limited hypoxic tumour environments, which are many types, due to its reliance on local oxygen levels. Moreover, single-modality approaches, phototherapy, often prove insufficient complete elimination, despite their therapeutic strength. In this paper, microfluidic-assisted approach was used create multifunctional silk-based (SFNPs) encapsulating chemotherapeutic Epirubicin (EPI), PTT/PDT agent CuS, heat-activated, oxygen-independent alkyl radical generator AIPH combined chemotherapy, PTT, PDT, with coating enhanced effects surface-bound folic acid (FA) targeted delivery treatment. The synthesised CuS-EPI-AIPH@SF-PDA-FA achieved controlled size 378 nm, strong NIR absorption, high efficiency. Under these selectively triggered release radicals EPI, improving intracellular levels effectively killing various cell lines while demonstrating low non-cancerous cells. We demonstrate novel core–shell NPs have been successfully designed nanoplatform integrating chemotherapy targeted, synergistic

Language: Английский

Citations

0

Development and evaluation of a model characterizing the release characteristics of a new letrozole long-acting injectable formulation DOI Creative Commons

Adriana Castiñeiras Pardines,

Gema López Ginés,

Gastón García Orueta

et al.

European Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 107103 - 107103

Published: April 1, 2025

Treating a chronic condition such as breast cancer usually requires daily oral drug administration for extended periods of time, which is associated with non-adherence to the prescribed therapy that may cause disease progression. New delivery strategies long-acting injectable (LAI) implants have entered picture in order solve drawbacks while improving bioavailability, plasma levels variability or treatment compliance. This has motivated development new polymeric and biodegradable situ forming implant letrozole. formulation provided kit two syringes (one them containing letrozole Poly-Lactic Acid, other one dimethyl sulfoxide solvent reconstitution). Once reconstituted injected into muscle, diffuses tissue fluids insoluble polymer precipitates, semi-solid traps API allows sustained release. In optimize both process, traditional vitro dissolution assessment predictive modelling were conducted identify characteristics show an impact on kinetics release, provide first basis potentially establish vitro-in vivo correlation (IVIVC) pre-clinical clinical data future. Two methods (real-time accelerated) used describe profiles 15 LAI formulations differing their Critical Material Attributes (CMAs). The release best described using Weibull distribution estimating fraction dose loss during injection. rate constant (KD) was increased by 1.87 times case accelerated conditions, 30% reduced 1.34 high low viscosity formulations, respectively. work allowed quantitative characterization related responsible controlling It provides understanding will serve guide robust product quality control specifications.

Language: Английский

Citations

0

Engineering Folic Acid‐Modified Nanoparticles to Enhance Letrozole's Anticancer Action DOI Creative Commons
Neda Rostami,

Abuzar Nikzad,

Shervin Shaybani

et al.

Macromolecular Bioscience, Journal Year: 2025, Volume and Issue: unknown

Published: April 18, 2025

Abstract The development of biodegradable nanoparticles (NPs) for delivering anticancer drugs, such as letrozole (LTZ), offers a targeted approach cancer therapy. In this study, we synthesized poly(ε‐caprolactone)‐ co ‐poly(ethylene glycol) (PCL‐ ‐PEG) and fabricated LTZ‐loaded PCL‐ ‐PEG NPs (LTZ‐NPs) via emulsion‐solvent evaporation. Folic acid (FA), folate receptor‐targeting molecule, was conjugated to the (LTZ‐FNPs) enhance treatment efficacy against hormone receptor‐positive breast cells. Both FNPs exhibited spherical morphology (60–90 nm), with showing higher drug entrapment efficiency controlled release. LTZ release minimal at physiological pH but increased in acidic, cancer‐like environments, following Korsmeyer‐Peppas model, indicating combination Fickian non‐Fickian diffusion. cytotoxicity assays, LTZ‐FNPs toxicity MCF‐7 cells than LTZ‐NPs. Controlled altered gene expression, reducing B‐cell leukemia/lymphoma 2 protein (Bcl2) increasing caspase 8 (Casp8), promoting apoptosis. A shift SubG1 phase further confirmed enhanced LTZ‐FNP‐mediated cell death. Furthermore, p53 expression increased, while matrix metalloproteinase 9 (MMP‐9) decreased, inhibiting invasion. This study introduces system FA‐functionalized, pH‐sensitive delivery LTZ. holds great potential selective, efficient minimizing systemic

Language: Английский

Citations

0

Advancements in small interfering RNAs therapy for acute lymphoblastic leukemia: promising results and future perspectives DOI
Amirhossein Rastgar, Setare Kheyrandish, Mahmoud Vahidi

et al.

Molecular Biology Reports, Journal Year: 2024, Volume and Issue: 51(1)

Published: June 14, 2024

Language: Английский

Citations

2